Nucleotide Metabolism Flashcards

1
Q

What are the two types of heterolytic rings?

A

Purines and pyrimidine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are nucleotides?

A

The phosphate esters of nucleosides

Nitrogenous base + sugar + phosphate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are nucleosides composed of?

A

Nitrogenous base + sugar

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

True or false: dATP is equivalent to ATP

A

False

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is different about a deoxynucleotide?

A

There is no OH group on C2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Hypoxanthine and xanthine are classified as purine or pyrimidines?

A

Purines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the two ways in which purines can be synthesized?

A

De novo synthesis and salvage pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Briefly describe de novo purine synthesis and its location

A

Site: liver, cytosol

Formation of purine base on ribose-5-phosphate from the PPP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Briefly describe the purine salvage pathway and its location

A

Site: organelles

Addition of ribose 5P to the preformed purine base

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the two ways in which pyrimidine nucleotide synthesis can occur?

A

De novo synthesis and the salvage pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Briefly describe de novo pyrimidine synthesis and its location

A

Site: liver, cytosol, mitochondria

Formation of pyrimidine ring structure followed by the addition of ribose phosphate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Briefly describe the pyrimidine salvage pathway and its location

A

Site: organelles

Formation of pyrimidine nucleotides from pyrimidine bases in RNA/DNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the phases of purine synthesis?

A
  1. Activation of ribose 5 phosphate
  2. Conversion of PRPP into phosphoribosylamine
  3. Construction of inosine monophosphate (branch point)
  4. Conversion of IMP into adenosine and guanosine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe phase I: activation of ribose 5 phosphate in purine synthesis

A

Starts with ribose 5 P which is a byproduct of the oxidative phase of the PPP
Converted to active form, 5-phosphate alpha D ribosyl - 1-pyrophosphate (PRPP)
Utilizes ATP and requires PRPP synthetase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Explain the specific roles of nucleosides and nucleotides

A

Nucleotides such as ATP and GTP are important cosubstrates in an array of enzymatic reactions
Nucleotides are also components of several cofactors, including CoA, FAD, FMN, UDP-Gln and NADPH and NADH
Nucleotides such as cAMP and cGMP play regulatory roles and serve as stabilizing energy elements
Nucleosides also appear in important biomolecules such as adenosine in vitamin B12

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is PRPP synthetase (phase I purine synthesis) regulated by?

A

Allosterically activated by phosphate levels (Pi levels signal cellular activity due to ATP consumption)
Negatively regulated by levels of purine nucleotides GMP, AMP and IMP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Describe phase II: conversion of PRPP into phosphoribosylamine in purine synthesis

A

Glutamine:phosphoribosyl pyrophospphate aminotransferase substitutes pyrophosphate with an amino group at C1 or PRPP
Obtains the amino group from glutamine
Generates phosphoribosylamine (PRA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is phase II of purine synthesis regulated by?

A

Allosterically positively regulated by PRPP levels

Negatively regulated by the levels of purine nucleotides GMP, AMP and IMP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Describe phase III: construction of inosine monophosphate in purine synthesis

A
PRA enters 9 step ring constructing sequence that produces IMP 
All intermediates are phosphorylated (nucleotides) due to the phosphate group on R5P
Consumes ATP(4) in reaching IMP 
IMP is the branch point in anabolism of purines
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Where do the C and N come from in purine synthesis?

A

2 C’s from folate derivative, 1 C from CO2, remaining C’s and N’s from amino acids Gln, Gly and Asp

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Describe phase IV: conversion of IMP into adenosine and guanosine in purine synthesis

A

Conversion of IMP to XMP is an oxidation reaction that requires NAD+
ATP and GTP are used in the synthesis of GMP and AMP respectively
Conversion of IMP to XMP is the RLS in GTP synthesis

22
Q

Describe the feedback inhibition that occurs in purine synthesis

A

Synthesis of PRPP, phosphoribosyl amine, AMP and GMP from IMP
Accumulation of these end products inhibit their own synthesis

23
Q

Describe the cross regulation that occurs in purine synthesis

A

AMP synthesis is stimulated by GTP

GMP synthesis is stimulated by ATP

24
Q

What are the phases of pyrimidine synthesis?

A
  1. Formation of pyrimidine ring as orotate
  2. Attachment of orotate to PRPP to generate uridine monophosphate (branch point)
  3. Conversion of uridine monophosphate into cytosine and thymidine (deoxy) nucleotides
25
Describe phase I: formation of pyrimidine ring as orotate in pyrimidine synthesis
RLS: formation of carbamoyl phosphate Last step that generates orotate is in the mitochondria, then orotate is transported to the cytosol Carbamoyl phosphate synthetase II is activated by PRPP and inhibited by UTP Defect in the urea cycle can result in elevated levels of carbamoyl phosphate and manifest as hyperammonia with orotic aciduria
26
Describe phase II: attachment of orotate to PRPP to generate uridine monophosphate (the branch point of pyrimidine synthesis)
UMP synthetase attaches orotate to PRPP to give orotidine monophosphate (OMP) UMP synthetase then decaroxylates OMP to generate UMP
27
Describe phase III: conversion of uridine monophosphate into cytosine and thymidine deoxynucleotides
UDP acts as a central portal to other pyrimidines dUDP loop is wasteful but through that this occurs so that dUTPase keeps dUTP low to prevent incorporating into DNA dUMP is bridge to thymidine production UTP is aminated to form CTP
28
Describe the key regulatory steps of pyrimidine synthesis
``` Carbamoyl phosphate synthetase is inhibited by UMP/UTP and stimulated by PRPP Aspartate transcarbamoylase (ATCase) is inhibited by CTP ```
29
Why is the PPP important?
In humans the PPP produces R5P and NADPH NADPH used to maintain reducing environments and to provide reducing power for biosynthesis of FAs Formation of glutathione as a key antioxidant Liver is principle site of purine and pyrimidine synthesis and utilizes R5P and 3/5 principle free amino acids in the liver (Asp, Gln, Gly) as starting materials
30
What is the difference between the source of atoms for C H O N in purines and pyrimidines?
Both use Gln, Asp, CO2 and N-formyl THF | Pyrimidine synthesis does not use Gly whereas purines do
31
What is methotrexate?
Anti-neoplastic agent used to treat cancer Targets dihydrofolate reductase (DHFR) which converts dietary folate to the biologically active tetrahydrofolate in the liver Prevents oxidation of NADPH Inhibition disrupts DNA replication in rapidly dividing cancer cells
32
What is fluorouracil?
Cancer treatment drug | Inhibits thymidine synthase and therefore inhibits thymidine pathway (dUMP -> dTMP)
33
What are sulfa drugs?
Antibacterial agents in the sulfa family that competitively inhibit the bacterial enzyme that incorporates p-aminobenzoic acid (PABA) into folate PABA is an intermediate in the synthesis of folate by bacteria, plants and fungi Sulfa drugs selectively disrupt DNA replication in bacteria Humans require folate as a vitamin in their diet and do not make it so these drugs are selective to bacteria
34
Describe the method of depriving cells of GMP and dGTP
Oxidative step in conversion of IMP to XMP is an opportunity of therapeutic intervention IMP dehydrogenase is the target Therapeutic agent is an immunosuppressant that disputes DNA replication in B and T cells Works by depriving them of adequate supplies of GMP and hence dGTP Disrupting GMP synthesis is useful in preventing transplant rejection
35
Describe purine catabolism
Removal of ribose from guanosine and inosine produces guanine and hypoxanthine Converges at formation of xanthine Largely converted to uric acid
36
Describe the role adenosine deaminase (ADA) plays in purine catabolism
Irreversible hydrolytic deamination Adenosine —> insosine Overproduction of erythrocyte isoform causes hemolytic anemia Underproduction associated with SCID
37
Describe the role xanthine oxidase plays in purine catabolism
Hypoxanthine —> xanthine —> uric acid | Target for gout tx
38
Describe the oxidation levels of purines
``` Typically catabolic processes include steps where oxygen is added to molecules to make them more polar Adenine = 0, guanine and hypoxanthine = 1 oxygen, xanthine = 2 oxygens and uric aid =3 oxygens Uric acid (the end point of catabolism) is the most oxidized and has an acidic hydrogen which makes it have limited solubility in water that plays a key role in gout ```
39
Describe how uric acid levels are used as a diagnostic marker for gout
Serum uric acid levels are diagnostic marker for gout Adult males 4-8.6mg/dL and females 3-5.9 Urinary urate levels are normally less than 750mg/24hr Serum urate levels >9 increase the risk of gout Urinary urate levels are variable day to day and are the most reliable when the patients are on a low purine diet
40
What is gout?
Characterized as high levels of uric acid in the blood Primary hyperuricemia —> overproduction of uric acid Secondary hyperuricemia —> underexcretion of uric acid Results in painful deposits of Na urate in the joints of extremities (gouty arthritis) Na urate deposits in the kidneys can also cause damage Diets rich in purines (beans, spinach, lentils) along with alcohol, meat and seafood can trigger episodes Tx includes reducing the amount of granulocytes to affected areas and allopurinol that inhibits xanthine oxidase Also proposed to increase levels of more soluble purines hypoxanthine and guanine
41
What is severe immunodeficiency (SCID)?
Fatal genetic disorder in which B and T cells are compromised Often males —> most common form is X linked Characterized by early onset (w/in first 3 months of life) of failure to thrive, chronic diarrhea, thrush and recurrent viral, bacterial, fungal and protozoal infection Mutations to the receptors shared by ILs involved in development and differentiation of B and T cells
42
What is ADA deficiency?
The second most common form of SCID (most pronounced in lymphocytes with high ADA activity) Leads to increased adenosine and decreased inosine Adenosine subsequently converted to AMP and ADP and then to dADP and dATP Increased dATP inhibits the activity site of ribonucleotide reductases that in turn blocks the formation of all other dNDPs Decreased dNDP and dNTP impairs DNA synthesis and leads to the compromised immune system
43
Describe pyrimidine catabolism
Converted to readily metabolized ketogenic or glucogenic water soluble compounds Malonyl CoA, methylmalonyl CoA and succinyl CoA Uracil/cytosine —> malonyl CoA (ketogenic) Thymine —> methyl malonyl CoA or succinyl CoA (glucogenic)
44
Describe nucleotide salvage pathways
Bases recovered during nucleotide turn over or digestion can be reincorporated into nucleotides Dominates de novo synthesis for purines Adenosine phosphoribosyltransferase (APRT) generates AMP Hypoxanthine-guanine phosphoribosyltransferase (HGPRT) generates GMP or IMP
45
Patients with <1.5% normal HGPRT activity
LNS presents with additional severe neurologic problems including spastic cerebral palsy, choreoathetosis and self destructive biting (fingers and lips)
46
Patients with >8% normal HGPRT activity
Kelley-Seegmiller syndrome results with gout and kidney destruction without neurologic sx
47
Patients with 8-15% normal HGPRT activity
Results in variant LNS with neurologic problems ranging from clumsiness to motor dysfunction Allopurinol can reduce joint and kidney problems but has not effect on neurological ones
48
What is Lesch-Nyan syndrome?
Results from defects in HGPRT in purine salvage pathway and is a rare form of primary hyperuricemia Hyperuricemia leads to gout, urate kidney stones, poor muscle control, mental retardation and tendency for self mutilation Normally levels of IMP and GMP are maintained in synthesis from PRPP and the salvage pathway mediated by HGPRT Excess purines are processed by nucleosidases and nucleotidases that convert GMP and IMP to guanosine and inosine and ultimately to uric acid
49
What do defects in the salvage pathway lead to in LNS?
Excess guanine and hypoxanthine not used in salvage pathway are shunted to form 6x normal levels of uric acid Purine biosynthesis proceeds at levels 200x normal and underlies the mental retardation and self mutilation PRPP which is not used in salvage pathway is available for additional purine biosynthesis and allosterically activates the next enzyme in purine biosynthesis Additional PRPP leading to more PRA has mass action effect on additional synthesis for more purines
50
What is acyclovir?
Thymidine kinase phosphorylates the nucleotide deoxythymidine (dT) to generate dTMP using ATP as the phosphoryl donor The antiviral agent that has a base resembling guanine undergoes phosphorylation by viral thymidine kinase at a rate that far exceeds that of cellular kinase This rapidly converts acyclovir to its monophosphate acyclo-dGMP which then gets converted to acyclo-dGTP and incorporated into rapidly dividing viral cells Acyclovir is used to help heal sores related to chicken pox, shingles and HPV